Erickson v. Abbott Laboratories et al
| Lena J Erickson |
| Merck, Sharpe, & Dohme Corporation, Wyeth-Ayerst Laboratories, Takeda Pharmaceuticals USA, Inc., Abbott Laboratories, Takeda Pharmaceuticals Company Limited, AstraZeneca LP, Novartis Vaccines and Diagnostics, Inc., Wyeth LLC, Novartis Consumer Health, Inc., Pfizer Inc, Novartis Pharmaceuticals Corporation, Novartis AG, GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, Novartis Institutes for Biomedical Research, Inc., Novartis Corporation, Takeda Development Center Americas Inc., Takeda Pharmaceuticals America, Inc., AstraZeneca Pharmaceuticals, LP, Wyeth-Ayerst Laboratories Company, The Procter & Gamble Company, Merck & Co., Inc. and The Procter & Gamble Manufacturing Company |
| 1:2019cv00509 |
| July 2, 2019 |
| US District Court for the Southern District of Ohio |
| Michael R Barrett |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 10, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 14
ORDER transferring case to District of New Jersey. Signed by Judge Michael R. Barrett on 7/10/2019. (ss)
|
| Case transferred to District of New Jersey.Case file and docket sheet sent Electronically. (ss) |
| Case transferred from Ohio Southern has been opened in District of New Jersey [LIVE] as case 2:19-cv-14982, filed 07/10/2019. (sct) |
| Filing 13 NOTICE of Appearance by Emily Serger Prem for Defendants The Procter & Gamble Company, The Procter & Gamble Manufacturing Company (Prem, Emily) |
| Filing 12 MOTION to Stay the Proceedings Pending Transfer to MDL by Defendants AstraZeneca LP, AstraZeneca Pharmaceuticals, LP, Merck & Co., Inc.. (Attachments: #1 Exhibit A-Notice of Potential Tag-Along Actions) (Anderson, Daniel) |
| Filing 11 NOTICE of Appearance by Robert Alexander Pitcairn, Jr for Defendants Pfizer Inc, Wyeth LLC, Wyeth-Ayerst Laboratories Company (Pitcairn, Robert) |
| Filing 10 ANSWER to #4 Complaint with Jury Demand filed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, Novartis Consumer Health, Inc.. (Woodside, Frank) |
| Filing 9 MOTION for Extension of Time to File Answer re #4 Complaint, #7 MOTION for Extension of Time to File Answer New date requested 12/31/2019. by Defendants Pfizer Inc, Wyeth LLC, Wyeth-Ayerst Laboratories Company. (O'Shea, Peter) |
| Filing 8 ANSWER to #4 Complaint with Jury Demand filed by Takeda Development Center Americas Inc., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals Company Limited, Takeda Pharmaceuticals USA, Inc.. (Brunton, Gregory) |
| If this case is referred, it will be to Magistrate Judge Stephanie K. Bowman. (bjc) |
| Filing 7 MOTION for Extension of Time to Answer or Otherwise Respond to Plaintiffs Complaint by Defendants AstraZeneca LP, AstraZeneca Pharmaceuticals, LP, Merck & Co., Inc.. (Attachments: #1 Text of Proposed Order) (Anderson, Daniel) Modified docket text on 7/9/2019 (sct). |
| Filing 6 NOTICE of Appearance by Daniel M Anderson for Defendants AstraZeneca LP, AstraZeneca Pharmaceuticals, LP, Merck & Co., Inc. (Anderson, Daniel) |
| Filing 5 NOTICE of Appearance by Kristina S. Dahmann for Defendants AstraZeneca LP, AstraZeneca Pharmaceuticals, LP, Merck & Co., Inc. (Dahmann, Kristina) |
| Filing 4 COMPLAINT with JURY DEMAND originally filed 5/31/2019 in Hamilton County Court of Common Pleas (Case No. A1902653) by Lena J Erickson against All Defendants. (eh) |
| Filing 3 Corporate Disclosure Statement by Defendants Merck, Sharpe, & Dohme Corporation, Merck Sharp & Dohme Corporation identifying Corporate Parent Merck Sharp & Dohme Corporation for Merck, Sharpe, & Dohme Corporation.. (Anderson, Daniel) |
| Filing 2 Corporate Disclosure Statement by Defendants AstraZeneca LP, AstraZeneca Pharmaceuticals, LP, AstraZeneca LP, AstraZeneca Pharmaceuticals, LP identifying Corporate Parent AstraZeneca Pharmaceuticals, LP for AstraZeneca Pharmaceuticals, LP; Corporate Parent AstraZeneca LP for AstraZeneca LP.. (Anderson, Daniel) |
| Filing 1 NOTICE OF REMOVAL from Hamilton County Common Pleas, case number A1902653 ( Filing fee $ 400 paid - receipt number: 0648-6993309), filed by Merck, Sharpe, & Dohme Corporation, AstraZeneca Pharmaceuticals, LP, AstraZeneca LP. (Attachments: #1 Exhibit A- State Court Record, #2 Exhibit B- MDL Order, #3 Exhibit C- Tolling Agreement, #4 Civil Cover Sheet, #5 Supplemental Civil Cover Sheet) (Anderson, Daniel) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Ohio Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
